Detalhe da pesquisa
1.
Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy.
Front Neurol
; 12: 652811, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33790852
2.
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
JCI Insight
; 3(22)2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429369
3.
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
JCI Insight
; 5(20)2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33055421